SCHEMBL29545839

SCHEMBL29545839

O=C(Nc1cccc(Br)c1)C1CC(F)CN1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRK2 P25098 1/20 0.49
▸ CASP6 P55212 1/20 0.49
▸ CASP8 Q14790 1/20 0.49
▸ CTDSP1 Q9GZU7 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ GAA P10253 1/20 0.43
▸ TGM2 P21980 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CTSC P53634 3/20 0.42
▸ CFD P00746 1/20 0.41
▸ P2RX1 P51575 1/20 0.41
▸ UBE2M P61081 1/20 0.41
▸ DCUN1D1 Q96GG9 1/20 0.41
▸ DPP4 P27487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18591145 1.00 GRK2 (0.49) GRK2CASP6CASP8CTDSP1TDP1
Hydrochloric Acid SCHEMBL18554739 0.99 GRK2 (0.48) GRK2CASP6CASP8CTDSP1TDP1
SCHEMBL29340506 0.84 GRK2 (0.49) GRK2CASP6CASP8CTDSP1TDP1
SCHEMBL29840719 0.84 MEN1 (0.50) TGM2MEN1NPC1LMNARAB9A
SCHEMBL18591149 0.84 MEN1 (0.50) TGM2MEN1NPC1LMNARAB9A
SCHEMBL31148140 0.83 CTSC (0.43) TGM2MEN1NPC1RAB9AKMT2A
SCHEMBL30945059 0.83 DPP4 (0.54) TDP1L3MBTL1GAATGM2MEN1
Hydrochloric Acid SCHEMBL18578488 0.83 MEN1 (0.49) TGM2MEN1NPC1LMNARAB9A
Hydrochloric Acid SCHEMBL31148064 0.82 CTSC (0.42) TGM2MEN1KMT2ACTSCDPP4
SCHEMBL20296977 0.82 EPHX2 (0.44) CTSCUBE2MDCUN1D1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4053117-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS Achillion Pharmaceuticals, Inc. (US) 2022-09-07 — — EP claimed
CN-114044800-A Aryl, heteroaryl and heterocyclic compounds for the treatment of medical disorders 艾其林医药公司 2022-02-15 — — CN disclosed
Send feedback